ข่าวประชาสัมพันธ์ ZP Therapeutics+Zuellig Pharma

Government Pharmaceutical Organization Confirms Purchase of Five Million Doses of COVID-19 Vaccine Moderna

The COVID-19 Vaccine Moderna will be available in Thailand from Q4, 2021 ZP Therapeutics, a division of Zuellig Pharma, a leading healthcare services provider in Asia, today announced an official agreement with the Government Pharmaceutical Organization (GPO) to supply and distribute five million doses of the COVID-19 Vaccine Moderna in Thailand from the fourth quarter of 2021. The two organisations will work closely with the Private Hospital Association (PHA) to expand access to alternative

Zuellig Pharma, a leading healthcare serv... Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia, has been awar...

Zuellig Pharma, a leading healthcare serv... Zuellig Pharma Clinches Ecovadis Gold Medal 2021 For Sustainability — Zuellig Pharma, a leading healthcare services provider in Asia has been awarded the ...

Zuellig Pharma ผู้ให้บริการเฮลธ์แคร์ระดับ... Zuellig Pharma คว้าเหรียญทอง Ecovadis ปี 2021 ด้านความยั่งยืน — Zuellig Pharma ผู้ให้บริการเฮลธ์แคร์ระดับชั้นนำในเอเชีย ได้รับรางวัล Gold Medal 2021 จากผู...

Zuellig Pharma ผู้ให้บริการดูแลสุขภาพชั้น... Zuellig Pharma แต่งตั้ง จอห์น เกรแฮม ดำรงตำแหน่งซีอีโอคนใหม่ — Zuellig Pharma ผู้ให้บริการดูแลสุขภาพชั้นนำในเอเชีย ประกาศแต่งตั้งคุณจอห์น เกรแฮม ดำรงตำแหน...

Zuellig Pharma, a leading healthcare serv... Zuellig Pharma appoints John Graham as new CEO — Zuellig Pharma, a leading healthcare services provider in Asia, announces the appointment of John Graham...

Zuellig Pharma, the region's leading heal... Photo Release: Zuellig Pharma announces investment in HBC — Zuellig Pharma, the region's leading healthcare services provider, signed an agreement to inve...

Zuellig Pharma, the region's leading heal... ZUELLIG PHARMA INVESTS IN HEALTH BENEFIT CONSULTANTS — Zuellig Pharma, the region's leading healthcare services provider, has today announced it has inves...

ภาพข่าว: “ซิลลิค ฟาร์มา” เปิดตัวนวัตกรรมใหม่ InnovativeHealthcare Solutions

เมื่อเร็วๆ นี้ นายอีฟส์ แอร์เมส Chief Executive บริษัท ซิลลิคฟาร์มา ประเทศไทย (ซ้าย) พร้อมกับ นายโรฟ เสตฟเฟน CEO Healthcare Services and Investments Zuellig Pharma Asia Pacific (ขวา) ผู้จัดจำหน่ายเวชภัณฑ์และผลิตภัณฑ์...

Photo Release: Zuellig Pharma Thailand Ltd.,staff party 2012 on theme “Space Adventure”

Mr. Yves Hermes Chief Executive of Zuellig Pharma Thailand Ltd., recently presided over an annual staff party 2012 on theme “Space Adventure”. The event took place at Convention Hall, Ambassador Hotel Bangkok...

Zuellig Pharma Names New Management Executive

Zuellig Pharma Ltd, leading healthcare products distributor in Thailand and across the Asia-Pacific region, has announced the appointment of Mr Ayusakorn Arayangkoon as Vice President Operations. Mr Ayusakorn brings with him extensive international and...

Zuellig Pharma Supports Thai Football

Zuellig Pharma Ltd, the leading healthcare product distributor in Thailand and across Asia-Pacific region, led by Mr Kovit Ophascharoensuk (front row-3rd from left), Vice President for Corporate Affairs, is seen presenting the ‘Perskindol’ gel to Mr Samart...

Photo Release: HM the King recently granted an audience with Mr Patrik Bruhlmann

HM the King recently granted an audience with Mr Patrik Bruhlmann (left), Chief Executive of Zuellig Pharma Ltd at Krai Kangwol Palace in Prabhuab Kirikhan province following a donation of 1,000,000 baht (one million...

Photo Release: Zuellig Pharma - donation for Tsunami victims

Mr Patrik Bruhlmann (far right), Chief Executive of Zuellig Pharma Thailand under the management of Interpharma Asia Pacific, together with Mr Fritz Horlacher (centre), Chief Executive-Asia Pacific of Interpharma Asia Pacific recently...

Photo Release: Zuellig Pharma names new Chief Executive

Zuellig Pharma Ltd, leading healthcare products distributor in Thailand and across Asia-Pacific region, has announced the appointment of Mr Patrik Bruhlmann as new Chief Executive. Mr Bruhlmann brings with him multiple skills to further develop...